Artisan Partners Seeks Management Change and M&A Action at Novartis

Artisan Partners, a shareholder of Novartis AG, has stated that the Swiss pharmaceutical company needs to make changes to its board of directors and improve its merger and acquisition strategy. According to a Reuters report, this demand comes after the company's share price fell sharply following failures in three major clinical trials. Artisan Partners has called for the renewal of Novartis's board of directors and strengthening its deal-making capability. The company's shares have depreciated as the clinical trial setbacks became public. The investor emphasized that the pharmaceutical giant needs to take urgent steps in these areas. Novartis has not yet made a statement on the matter. Not investment advice.

📊 NVS — Piyasa Yorumu

▼ down · 60%

The news indicates that an activist shareholder (Artisan Partners) is seeking management change and a merger move at Novartis. Such pressures often create short-term uncertainty and may cause selling pressure on the stock. However, the stock has already fallen 15.5% in the last 24 hours and the RSI is at 16, in oversold territory. This increases the likelihood of a short-term rebound, so our confidence in the downside is low. The MACD is negative and the price is below the SMA20, so the technical picture is weak. Nevertheless, the impact of the news may be limited because the market may have already priced in such activist calls.

RSI 14

16.1

MACD

-5.54

24h Δ

-15.53%

Canlı Grafikler